45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
22,303
Insurances with rates
4
CPT / HCPCS codes
20,565
Source MRF
Most expensive procedures (gross)
J0225
$215,961
VUTRISIRAN SODIUM 25 MG/0.5ML SC SOSY
Gross
$1,661,240
J9043
$114,996
CABAZITAXEL (JEVTANA) 10 MG/ML DILUTION
Gross
$884,584
J9347
$75,109
TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN
Gross
$577,765
J2507
$55,792
PEGLOTICASE 8 MG/ML IV SOLN
Gross
$429,173
J3357
$51,581
USTEKINUMAB 90 MG/ML SC SOSY
Gross
$396,781
J2350
$37,459
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$288,148
J3241
$32,701
TEPROTUMUMAB-TRBW 500 MG IV SOLR
Gross
$251,545
J9334
$29,197
EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN
Gross
$224,595
J1628
$26,422
GUSELKUMAB 200 MG/20ML IV SOLN
Gross
$203,246
J9042
$24,154
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$185,802
93653
$23,956
HC EP COMP STUDY W/ABLATION SVT/FLUTTER
Gross
$184,280
93654
$23,869
HC EP COMP STUDY W/ABLATION VT W/WO MAPPING
Gross
$183,604
Q0480
$82,775
PR DRIVER PNEUMATIC VAD, REP
Gross
$176,117
93656
$22,699
HC EP COMP STUDY W/ABLATION AFIB W/TRANSSEPTAL
Gross
$174,606
J2329
$21,171
UBLITUXIMAB-XIIY 150 MG/6ML IV SOLN
Gross
$162,851
J1440
$20,192
FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP
Gross
$155,325
J9119
$19,827
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$152,513
J9144
$19,090
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$146,846
J3263
$18,146
TORIPALIMAB-TPZI 240 MG/6ML IV SOLN
Gross
$139,582
J1930
$17,353
SOMATULINE DEPOT 120 MG/0.5ML SC SOLN
Gross
$133,486
J9228
$17,254
IPILIMUMAB 50 MG/10ML IV SOLN
Gross
$132,725
J3380
$16,986
VEDOLIZUMAB 300 MG IV SOLR
Gross
$130,665
J9301
$16,334
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$125,644
J2323
$16,114
NATALIZUMAB 300 MG/15ML IV CONC
Gross
$123,954
J9223
$15,721
LURBINECTEDIN 4 MG IV SOLR
Gross
$120,929
92941
$15,582
HC PCI CORONARY AMI ACUTE OCCL INITIAL VESSEL RC
Gross
$119,860
92943
$15,582
HC PCI CORONARY CHRONIC OCCL INITIAL VESSL RC
Gross
$119,860
33249
$15,582
HC ICD INSERT SINGLE/DUAL W/FLUORO
Gross
$119,860
C9604
$15,582
HC PCI CORONARY DES GRAFT INITIAL VESSEL LM
Gross
$119,860
C9606
$15,582
HC PCI CORONARY DES AMI ACUTE OCCL INITAL VESSEL LC
Gross
$119,860
33231
$15,582
HC ICD BIVENT INSERT GENERATOR ONLY W/FLUORO
Gross
$119,860
33264
$15,582
HC ICD BIVENT GENERATOR CHANGE W/FLUORO
Gross
$119,860
33274
$15,576
HC TCAT INSJ/RPL PERM LDLS PM
Gross
$119,817
33270
$15,567
HC ICD INSERT SUBQ
Gross
$119,749
33230
$15,440
HC ICD INSERT GENERATOR ONLY DUAL LEADS W/FLUORO
Gross
$118,768
33263
$15,440
HC ICD GENERATOR CHANGE DUAL LEAD W/FLUORO
Gross
$118,768
33240
$15,342
HC ICD INSERT GENERATOR ONLY SINGLE LEAD W/FLUOR
Gross
$118,018
33262
$15,342
HC ICD GENERATOR CHANGE SINGLE LEAD W/FLUORO
Gross
$118,018
J2327
$15,244
RISANKIZUMAB-RZAA 600 MG/10ML IV SOLN
Gross
$117,264
J3101
$14,838
TENECTEPLASE 50 MG IV KIT
Gross
$114,139
J9022
$14,723
ATEZOLIZUMAB 840 MG/14ML IV SOLN
Gross
$113,252
J9308
$14,299
RAMUCIRUMAB 500 MG/50ML IV SOLN
Gross
$109,993
36906
$14,103
HC THROMBECTOMY A-V SHUNT W ANGIOP W STENT
Gross
$108,484
J9273
$14,103
TISOTUMAB VEDOTIN-TFTV 40 MG IV SOLR
Gross
$108,481
36226
$14,033
HC VERTEBRAL ANGIO W S/I
Gross
$107,942
J9303
$12,821
PANITUMUMAB 400 MG/20ML IV SOLN
Gross
$98,624
37236
$12,705
HC INSERT INTRAVASCULAR STENT INITIAL W S/I
Gross
$97,727
37238
$12,705
HC INSERT INTRAVASCULAR STENT VENOUS INITIAL W S/I
Gross
$97,727
36908
$12,697
HC ANGIOPLASTY A-V SHUNT W STENT CENT SEG
Gross
$97,672
33214
$12,676
HC PACEMAKER SINGLE UPGRADE TO DUAL
Gross
$97,506
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN SODIUM 25 MG/0.5ML SC SOSY | $1,661,240 | $215,961 | — | — | 6 |
| J9043 | CABAZITAXEL (JEVTANA) 10 MG/ML DILUTION | $884,584 | $114,996 | — | — | 12 |
| J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $577,765 | $75,109 | — | — | 6 |
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $429,173 | $55,792 | — | — | 6 |
| J3357 | USTEKINUMAB 90 MG/ML SC SOSY | $396,781 | $51,581 | — | — | 6 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $288,148 | $37,459 | — | — | 6 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $251,545 | $32,701 | — | — | 6 |
| J9334 | EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN | $224,595 | $29,197 | — | — | 6 |
| J1628 | GUSELKUMAB 200 MG/20ML IV SOLN | $203,246 | $26,422 | — | — | 6 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $185,802 | $24,154 | — | — | 6 |
| 93653 | HC EP COMP STUDY W/ABLATION SVT/FLUTTER | $184,280 | $23,956 | — | — | 6 |
| 93654 | HC EP COMP STUDY W/ABLATION VT W/WO MAPPING | $183,604 | $23,869 | — | — | 6 |
| Q0480 | PR DRIVER PNEUMATIC VAD, REP | $176,117 | $82,775 | — | — | 3 |
| 93656 | HC EP COMP STUDY W/ABLATION AFIB W/TRANSSEPTAL | $174,606 | $22,699 | — | — | 6 |
| J2329 | UBLITUXIMAB-XIIY 150 MG/6ML IV SOLN | $162,851 | $21,171 | — | — | 6 |
| J1440 | FECAL MICROBIOTA, LIVE-JSLM 150 ML RE SUSP | $155,325 | $20,192 | — | — | 12 |
| J9119 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $152,513 | $19,827 | — | — | 6 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $146,846 | $19,090 | — | — | 6 |
| J3263 | TORIPALIMAB-TPZI 240 MG/6ML IV SOLN | $139,582 | $18,146 | — | — | 6 |
| J1930 | SOMATULINE DEPOT 120 MG/0.5ML SC SOLN | $133,486 | $17,353 | — | — | 6 |
| J9228 | IPILIMUMAB 50 MG/10ML IV SOLN | $132,725 | $17,254 | — | — | 6 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $130,665 | $16,986 | — | — | 6 |
| J9301 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $125,644 | $16,334 | — | — | 6 |
| J2323 | NATALIZUMAB 300 MG/15ML IV CONC | $123,954 | $16,114 | — | — | 6 |
| J9223 | LURBINECTEDIN 4 MG IV SOLR | $120,929 | $15,721 | — | — | 6 |
| 92941 | HC PCI CORONARY AMI ACUTE OCCL INITIAL VESSEL RC | $119,860 | $15,582 | — | — | 3 |
| 92943 | HC PCI CORONARY CHRONIC OCCL INITIAL VESSL RC | $119,860 | $15,582 | — | — | 6 |
| 33249 | HC ICD INSERT SINGLE/DUAL W/FLUORO | $119,860 | $15,582 | — | — | 6 |
| C9604 | HC PCI CORONARY DES GRAFT INITIAL VESSEL LM | $119,860 | $15,582 | — | — | 6 |
| C9606 | HC PCI CORONARY DES AMI ACUTE OCCL INITAL VESSEL LC | $119,860 | $15,582 | — | — | 3 |
| 33231 | HC ICD BIVENT INSERT GENERATOR ONLY W/FLUORO | $119,860 | $15,582 | — | — | 6 |
| 33264 | HC ICD BIVENT GENERATOR CHANGE W/FLUORO | $119,860 | $15,582 | — | — | 6 |
| 33274 | HC TCAT INSJ/RPL PERM LDLS PM | $119,817 | $15,576 | — | — | 6 |
| 33270 | HC ICD INSERT SUBQ | $119,749 | $15,567 | — | — | 6 |
| 33230 | HC ICD INSERT GENERATOR ONLY DUAL LEADS W/FLUORO | $118,768 | $15,440 | — | — | 6 |
| 33263 | HC ICD GENERATOR CHANGE DUAL LEAD W/FLUORO | $118,768 | $15,440 | — | — | 6 |
| 33240 | HC ICD INSERT GENERATOR ONLY SINGLE LEAD W/FLUOR | $118,018 | $15,342 | — | — | 6 |
| 33262 | HC ICD GENERATOR CHANGE SINGLE LEAD W/FLUORO | $118,018 | $15,342 | — | — | 6 |
| J2327 | RISANKIZUMAB-RZAA 600 MG/10ML IV SOLN | $117,264 | $15,244 | — | — | 6 |
| J3101 | TENECTEPLASE 50 MG IV KIT | $114,139 | $14,838 | — | — | 12 |
| J9022 | ATEZOLIZUMAB 840 MG/14ML IV SOLN | $113,252 | $14,723 | — | — | 6 |
| J9308 | RAMUCIRUMAB 500 MG/50ML IV SOLN | $109,993 | $14,299 | — | — | 6 |
| 36906 | HC THROMBECTOMY A-V SHUNT W ANGIOP W STENT | $108,484 | $14,103 | — | — | 6 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG IV SOLR | $108,481 | $14,103 | — | — | 6 |
| 36226 | HC VERTEBRAL ANGIO W S/I | $107,942 | $14,033 | — | — | 6 |
| J9303 | PANITUMUMAB 400 MG/20ML IV SOLN | $98,624 | $12,821 | — | — | 6 |
| 37236 | HC INSERT INTRAVASCULAR STENT INITIAL W S/I | $97,727 | $12,705 | — | — | 6 |
| 37238 | HC INSERT INTRAVASCULAR STENT VENOUS INITIAL W S/I | $97,727 | $12,705 | — | — | 6 |
| 36908 | HC ANGIOPLASTY A-V SHUNT W STENT CENT SEG | $97,672 | $12,697 | — | — | 6 |
| 33214 | HC PACEMAKER SINGLE UPGRADE TO DUAL | $97,506 | $12,676 | — | — | 6 |
Showing top 50 of 22,303 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.